Plain-English translation of NCT07201519 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new way to deliver cancer medicine called hepatic artery infusion chemotherapy using a surgically placed pump. Instead of receiving chemotherapy through your veins like usual, the pump sends the medicine directly to your liver through the blood vessel that feeds it. The trial wants to see if this approach is safe and whether patients can have the pump refilled at home or at their local cancer center instead of always going to a large hospital.
Many people with colorectal cancer or certain bile duct cancers develop tumors in the liver that are hard to treat with standard chemotherapy. This treatment aims to deliver higher doses of medicine directly where the cancer is, which may work better, while also making care more convenient by allowing refills closer to home.
You likely qualify if…
You likely don't qualify if…
You will have surgery to place the pump into the blood vessel that supplies your liver. After surgery, you can choose to receive your cancer care either at the hospital as usual (with visits every two weeks), or at a community cancer clinic closer to home where a nurse will refill your pump and you'll have video visits with your doctor. The main treatment lasts about 3 to 4 months, during which you'll receive the medication through the pump and have regular check-ups to monitor how you're doing.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
United States